Literature DB >> 11096553

Transposition of the Great Arteries.

.   

Abstract

Transposition of the great arteries (TGA) is a lethal condition without intervention. Cross-sectional echocardiography is the diagnostic investigation of choice. Intravenous infusion of prostaglandin is employed to maintain ductal patency and allow mixing of blood, thus improving tissue oxygenation. Balloon atrial septostomy is recommended once the diagnosis is made. The arterial switch is accepted as the best option for simple TGA. Late follow-up includes survivors of the intra-atrial repair (Mustard and Senning operations), and the emerging cohort of survivors of the arterial switch procedure. Arrhythmia, baffle stenosis, tricuspid valve dysfunction, systemic ventricular dysfunction, and sudden death may occur late during follow-up after the Mustard or Senning procedure. There are less data for late follow-up after arterial switch; however, late death is rare, usually is related to reoperation, and important arrhythmias are uncommon. The long-term fate of the coronary circulation is unknown but coronary arterial obstruction has been reported. Continuing long-term surveillance is essential to detect the development of late problems in all groups of survivors.

Entities:  

Year:  2000        PMID: 11096553     DOI: 10.1007/s11936-000-0045-7

Source DB:  PubMed          Journal:  Curr Treat Options Cardiovasc Med        ISSN: 1092-8464


  30 in total

1.  Anatomical risk factors for mortality and cardiac morbidity after arterial switch operation.

Authors:  S H Daebritz; G Nollert; J S Sachweh; W Engelhardt; G von Bernuth; B J Messmer
Journal:  Ann Thorac Surg       Date:  2000-06       Impact factor: 4.330

2.  Surgical correction of transposition of the great vessels.

Authors:  A SENNING
Journal:  Surgery       Date:  1959-06       Impact factor: 3.982

3.  Internal mammary artery bypass after the arterial switch operation.

Authors:  K S Rheuban; I L Kron; A Bulatovic
Journal:  Ann Thorac Surg       Date:  1990-07       Impact factor: 4.330

4.  Echocardiographic evaluation of the ductal morphology in patients with refractoriness to lipo-prostaglandin E1 therapy.

Authors:  N Takeda; S Hiraishi; H Misawa; Y Agata; Y Horiguchi; N Fujino; H Hirota; S Kawamura; N Ogawa
Journal:  Pediatr Int       Date:  2000-04       Impact factor: 1.524

5.  Creation of an atrial septal defect without thoracotomy. A palliative approach to complete transposition of the great arteries.

Authors:  W J Rashkind; W W Miller
Journal:  JAMA       Date:  1966-06-13       Impact factor: 56.272

6.  Morphogenesis of bulboventricular malformations. II. Observations on malformed hearts.

Authors:  R H Anderson; J L Wilkinson; R Arnold; A E Becker; K Lubkiewicz
Journal:  Br Heart J       Date:  1974-10

Review 7.  Scientific, ethical, and logistical considerations in introducing a new operation: a retrospective cohort study from paediatric cardiac surgery.

Authors:  C Bull; R Yates; D Sarkar; J Deanfield; M de Leval
Journal:  BMJ       Date:  2000-04-29

8.  Sequential chamber localization--logical approach to diagnosis in congenital heart disease.

Authors:  E A Shinebourne; F J Macartney; R H Anderson
Journal:  Br Heart J       Date:  1976-04

9.  Recurrence risks in offspring of adults with major heart defects: results from first cohort of British collaborative study.

Authors:  J Burn; P Brennan; J Little; S Holloway; R Coffey; J Somerville; N R Dennis; L Allan; R Arnold; J E Deanfield; M Godman; A Houston; B Keeton; C Oakley; O Scott; E Silove; J Wilkinson; M Pembrey; A S Hunter
Journal:  Lancet       Date:  1998-01-31       Impact factor: 79.321

10.  Sympathetic denervation and reinnervation after arterial switch operation for complete transposition.

Authors:  C Kondo; M Nakazawa; K Momma; K Kusakabe
Journal:  Circulation       Date:  1998-06-23       Impact factor: 29.690

View more
  1 in total

1.  Long term outcome up to 30 years after the Mustard or Senning operation: a nationwide multicentre study in Belgium.

Authors:  P Moons; M Gewillig; T Sluysmans; H Verhaaren; P Viart; M Massin; B Suys; W Budts; A Pasquet; D De Wolf; A Vliers
Journal:  Heart       Date:  2004-03       Impact factor: 5.994

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.